A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated RejectionKatharina A. Mayer, Georg A. Böhmig, Martina Schatzl et al.|New England Journal of Medicine|2024Cited by 151
Functional Natural Killer-cell Genetics and Microvascular Inflammation After Kidney Transplantation: An Observational Cohort StudyMatthias Diebold, Georg A. Böhmig, Hannes Vietzen et al.|Transplantation|2024Cited by 13